CombiMatrix Corporation is a biotechnology company, with a subsidiary, CombiMatrix Molecular Diagnostics, Inc. (CMDX). The Company develops technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology and defense, and homeland security markets. The technologies it has developed include a platform technology to rapidly produce user-defined, in-situ synthesized, oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations, and proteins. This technology has a range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology. Other technologies include molecular synthesis and screening methods for the discovery of potential new drugs.